Original Research
19 May 2015

Identifying Women With Dense Breasts at High Risk for Interval Cancer: A Cohort Study

Publication: Annals of Internal Medicine
Volume 162, Number 10

Abstract

Background:

Twenty-one states have laws requiring that women be notified if they have dense breasts and that they be advised to discuss supplemental imaging with their provider.

Objective:

To better direct discussions of supplemental imaging by determining which combinations of breast cancer risk and Breast Imaging Reporting and Data System (BI-RADS) breast density categories are associated with high interval cancer rates.

Design:

Prospective cohort.

Setting:

Breast Cancer Surveillance Consortium (BCSC) breast imaging facilities.

Patients:

365 426 women aged 40 to 74 years who had 831 455 digital screening mammography examinations.

Measurements:

BI-RADS breast density, BCSC 5-year breast cancer risk, and interval cancer rate (invasive cancer ≤12 months after a normal mammography result) per 1000 mammography examinations. High interval cancer rate was defined as more than 1 case per 1000 examinations.

Results:

High interval cancer rates were observed for women with 5-year risk of 1.67% or greater and extremely dense breasts or 5-year risk of 2.50% or greater and heterogeneously dense breasts (24% of all women with dense breasts). The interval rate of advanced-stage disease was highest (>0.4 case per 1000 examinations) among women with 5-year risk of 2.50% or greater and heterogeneously or extremely dense breasts (21% of all women with dense breasts). Five-year risk was low to average (0% to 1.66%) for 51.0% of women with heterogeneously dense breasts and 52.5% with extremely dense breasts, with interval cancer rates of 0.58 to 0.63 and 0.72 to 0.89 case per 1000 examinations, respectively.

Limitation:

The benefit of supplemental imaging was not assessed.

Conclusion:

Breast density should not be the sole criterion for deciding whether supplemental imaging is justified because not all women with dense breasts have high interval cancer rates. BCSC 5-year risk combined with BI-RADS breast density can identify women at high risk for interval cancer to inform patient–provider discussions about alternative screening strategies.

Primary Funding Source:

National Cancer Institute.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Boyd NFGuo HMartin LJSun LStone JFishell Eet al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-36. [PMID: 17229950]
2.
Are You Dense Advocacy Web site. Accessed at www.areyoudenseadvocacy.org on 24 March 2015.
3.
American College of Radiology. The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
4.
Kerlikowske K. The mammogram that cried Wolfe [Editorial]. N Engl J Med. 2007;356:297-300. [PMID: 17229958]
5.
Sprague BLGangnon REBurt VTrentham-Dietz AHampton JMWellman RDet al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014;106. [PMID: 25217577]  doi: 10.1093/jnci/dju255
6.
U.S. Food and Drug Administration. MQSA National Statistics. Silver Spring, MD: U.S. Food and Drug Administration; 2014. Accessed at www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/FacilityScorecard/ucm113858.htm on 21 September 2014.
7.
Kerlikowske KHubbard RAMiglioretti DLGeller BMYankaskas BCLehman CDet alBreast Cancer Surveillance Consortium. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155:493-502. [PMID: 22007043]  doi: 10.7326/0003-4819-155-8-201110180-00005
8.
Berg WABlume JDCormack JBMendelson EBLehrer DBöhm-Vélez Met alACRIN 6666 Investigators. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151-63. [PMID: 18477782]  doi: 10.1001/jama.299.18.2151
9.
Porter PLEl-Bastawissi AYMandelson MTLin MGKhalid NWatney EAet al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999;91:2020-8. [PMID: 10580027]
10.
Nederend JDuijm LELouwman MWCoebergh JWRoumen RMLohle PNet al. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment—a population based study from the Netherlands. Eur J Cancer. 2014;50:31-9. [PMID: 24275518]  doi: 10.1016/j.ejca.2013.09.018
11.
Drukker CASchmidt MKRutgers EJCardoso FKerlikowske KEsserman LJet al. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res Treat. 2014;144:103-11. [PMID: 24469641]  doi: 10.1007/s10549-013-2830-5
12.
Tice JACummings SRSmith-Bindman RIchikawa LBarlow WEKerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148:337-47. [PMID: 18316752]  doi: 10.7326/0003-4819-148-5-200803040-00004
13.
Rockhill BSpiegelman DByrne CHunter DJColditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93:358-66. [PMID: 11238697]
14.
Vachon CMPankratz VSScott CGHaeberle LZiv EJensen MRet al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015;107. [PMID: 25745020]  doi: 10.1093/jnci/dju397
15.
Ballard-Barbash RTaplin SHYankaskas BCErnster VLRosenberg RDCarney PAet al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997;169:1001-8. [PMID: 9308451]
16.
Sickles EAMiglioretti DLBallard-Barbash RGeller BMLeung JWRosenberg RDet al. Performance benchmarks for diagnostic mammography. Radiology. 2005;235:775-90. [PMID: 15914475]
17.
Ernster VLBallard-Barbash RBarlow WEZheng YWeaver DLCutter Get al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546-54. [PMID: 12381707]
18.
Yankaskas BCTaplin SHIchikawa LGeller BMRosenberg RDCarney PAet al. Association between mammography timing and measures of screening performance in the United States. Radiology. 2005;234:363-73. [PMID: 15670994]
19.
Kerlikowske KMolinaro ACha ILjung BMErnster VLStewart Ket al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95:1692-702. [PMID: 14625260]
20.
American Joint Committee on Cancer. Manual for Staging of Cancer. 6th ed. Philadelphia: JB Lippincott; 2002.
21.
Vogel VGCostantino JPWickerham DLCronin WMCecchini RSAtkins JNet alNational Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295:2727-41. [PMID: 16754727]
22.
Carney PASickles EAMonsees BSBassett LWBrenner RJFeig SAet al. Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology. 2010;255:354-61. [PMID: 20413750]  doi: 10.1148/radiol.10091636
23.
Liang KYZeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
24.
Clopper CJPearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404-13.
25.
Saadatmand SRutgers EJTollenaar RAZonderland HMAusems MGKeymeulen KBet al. Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial. BMC Cancer. 2012;12:440. [PMID: 23031619]  doi: 10.1186/1471-2407-12-440
26.
Kerlikowske KCook AJBuist DSCummings SRVachon CVacek Pet al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28:3830-7. [PMID: 20644098]  doi: 10.1200/JCO.2009.26.4770
27.
Berg WAZhang ZLehrer DJong RAPisano EDBarr RGet alACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307:1394-404. [PMID: 22474203]  doi: 10.1001/jama.2012.388
28.
Nothacker MDuda VHahn MWarm MDegenhardt FMadjar Het al. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. 2009;9:335. [PMID: 19765317]  doi: 10.1186/1471-2407-9-335
29.
Hooley RJGreenberg KLStackhouse RMGeisel JLButler RSPhilpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology. 2012;265:59-69. [PMID: 22723501]
30.
Weigert JSteenbergen S. The Connecticut experiment: the role of ultrasound in the screening of women with dense breasts. Breast J. 2012;18:517-22. [PMID: 23009208]  doi: 10.1111/tbj.12003
31.
Parris TWakefield DFrimmer H. Real world performance of screening breast ultrasound following enactment of Connecticut Bill 458. Breast J. 2013;19:64-70. [PMID: 23240937]  doi: 10.1111/tbj.12053
32.
Carney PAMiglioretti DLYankaskas BCKerlikowske KRosenberg RRutter CMet al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168-75. [PMID: 12558355]  doi: 10.7326/0003-4819-138-3-200302040-00008
33.
Kerlikowske KZhu WHubbard RAGeller BDittus KBraithwaite Det alBreast Cancer Surveillance Consortium. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173:807-16. [PMID: 23552817]  doi: 10.1001/jamainternmed.2013.307
34.
Bertrand KATamimi RMScott CGJensen MRPankratz VVisscher Det al. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res. 2013;15:R104. [PMID: 24188089]  doi: 10.1186/bcr3570
35.
Yaghjyan LColditz GACollins LCSchnitt SJRosner BVachon Cet al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011;103:1179-89. [PMID: 21795664]  doi: 10.1093/jnci/djr225
36.
Hubbard RAKerlikowske KFlowers CIYankaskas BCZhu WMiglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481-92. [PMID: 22007042]  doi: 10.7326/0003-4819-155-8-201110180-00004
37.
Haas BMKalra VGeisel JRaghu MDurand MPhilpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology. 2013;269:694-700. [PMID: 23901124]  doi: 10.1148/radiol.13130307
38.
Rafferty EAPark JMPhilpotts LEPoplack SPSumkin JHHalpern EFet al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology. 2013;266:104-13. [PMID: 23169790]  doi: 10.1148/radiol.12120674
39.
Skaane PBandos AIGullien REben EBEkseth UHaakenaasen Uet al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47-56. [PMID: 23297332]  doi: 10.1148/radiol.12121373
40.
McCarthy AMKontos DSynnestvedt MTan KSHeitjan DFSchnall Met al. Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. J Natl Cancer Inst. 2014;106. [PMID: 25313245]  doi: 10.1093/jnci/dju316
41.
Friedewald SMRafferty EARose SLDurand MAPlecha DMGreenberg JSet al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311:2499-507. [PMID: 25058084]  doi: 10.1001/jama.2014.6095
42.
Antoni SSasco AJdos Santos Silva IMcCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat. 2013;137:337-47. [PMID: 23239150]  doi: 10.1007/s10549-012-2362-4

Comments

0 Comments
Sign In to Submit A Comment

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 162Number 1019 May 2015
Pages: 673 - 681

History

Published online: 19 May 2015
Published in issue: 19 May 2015

Keywords

Authors

Affiliations

Karla Kerlikowske, MD
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Weiwei Zhu, MS
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Anna N.A. Tosteson, ScD
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Brian L. Sprague, PhD
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Jeffrey A. Tice, MD
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Constance D. Lehman, MD, PhD
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Diana L. Miglioretti, PhD
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
for the Breast Cancer Surveillance Consortium
From the University of California, San Francisco, San Francisco, California; Group Health Cooperative and University of Washington School of Medicine, Seattle, Washington; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; University of Vermont, Burlington, Vermont; and University of California, Davis, Davis, California.
Acknowledgment: The authors thank the participating women, mammography facilities, and radiologists for the data they provided for this study. A list of the BCSC investigators and procedures for requesting BCSC data for research purposes are provided at http://breastscreening.cancer.gov.
Grant Support: This work was supported by the National Cancer Institute–funded BCSC (P01 CA154292, HHSN261201100031C, and U54 CA163303). The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. A full description of these sources is available at http://breastscreening.cancer.gov/work/acknowledgement.html.
Reproducible Research Statement: Study protocol and statistical code: Available from the BCSC's statistical coordinating center (e-mail, [email protected]). Data set: Available with approval of the BCSC Steering Committee (http://breastscreening.cancer.gov).
Corresponding Author: Karla Kerlikowske, MD, San Francisco Veterans Affairs Medical Center, General Internal Medicine Section, 111A1, 4150 Clement Street, San Francisco, CA 94121.
Current Author Addresses: Dr. Kerlikowske: San Francisco Veterans Affairs Medical Center, General Internal Medicine Section, 111A1, 4150 Clement Street, San Francisco, CA 94121.
Ms. Zhu: Group Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101.
Dr. Tosteson: Geisel School of Medicine at Dartmouth, One Medical Center Drive (HB7505), Lebanon, NH 03756.
Dr. Sprague: Office of Health Promotion Research, 1 South Prospect Street, Burlington, VT 05446.
Dr. Tice: Associate Professor of Medicine, University of California, San Francisco, 1545 Divisadero, 309, San Francisco, CA 94143-0320.
Dr. Lehman: University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G2-600, Seattle, WA 98109.
Dr. Miglioretti: UC Davis School of Medicine, Department of Public Health Sciences, One Shields Avenue, Med Sci 1C, Room 145, Davis, CA 95616.
Author Contributions: Conception and design: K. Kerlikowske, B.L. Sprague, D.L. Miglioretti.
Analysis and interpretation of the data: K. Kerlikowske, W. Zhu, A.N.A. Tosteson, B.L. Sprague, J.A. Tice, C.D. Lehman, D.L. Miglioretti.
Drafting of the article: K. Kerlikowske.
Critical revision of the article for important intellectual content: K. Kerlikowske, A.N.A. Tosteson, B.L. Sprague, J.A. Tice, C.D. Lehman, D.L. Miglioretti.
Final approval of the article: K. Kerlikowske, W. Zhu, A.N.A. Tosteson, B.L. Sprague, J.A. Tice, C.D. Lehman, D.L. Miglioretti.
Provision of study materials or patients: K. Kerlikowske.
Statistical expertise: K. Kerlikowske, W. Zhu, D.L. Miglioretti.
Obtaining of funding: K. Kerlikowske, A.N.A. Tosteson, B.L. Sprague, D.L. Miglioretti.
Administrative, technical, or logistic support: K. Kerlikowske.
Collection and assembly of data: K. Kerlikowske, W. Zhu, B.L. Sprague, D.L. Miglioretti.
* For a list of Breast Cancer Surveillance Consortium investigators, see the Appendix.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Karla Kerlikowske, Weiwei Zhu, Anna N.A. Tosteson, et al; for the Breast Cancer Surveillance Consortium . Identifying Women With Dense Breasts at High Risk for Interval Cancer: A Cohort Study. Ann Intern Med.2015;162:673-681. [Epub 19 May 2015]. doi:10.7326/M14-1465

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media